{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:30:06Z","timestamp":1792024206551,"version":"4.4.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Liver transplantation (LT) remains the most effective treatment for patients with hepatocellular carcinoma (HCC), offering 5-y recurrence rates as low as 15%. Recent advances in organ preservation, particularly hypothermic oxygenated machine perfusion (HOPE), have demonstrated the ability to attenuate ischemia\u2013reperfusion injury (IRI). However, whether HOPE can reduce HCC recurrence rates by mitigating IRI remains an open question. In this study, we aimed to compare oncological outcomes after LT for HCC with and without the use of HOPE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study including 137 patients who underwent LT for HCC with grafts from donation after brain death. Risk factors for HCC recurrence were analyzed using Cox regression. To assess the impact of HOPE on oncological outcomes, propensity score matching was used to adjust for baseline differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>Cox regression identified Milan Criteria status as a significant predictor of HCC recurrence. Among the 32 patients in the HOPE group, no HCC recurrence was observed over a median follow-up of 2.11 y. In contrast, within the control group of 105 patients, 8 (7.6%) experienced recurrence within 2 y posttransplantation. Although this translated into a significant difference in time-to-recurrence after propensity score matching, recurrence-free survival and overall survival did not differ significantly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Our findings suggest that HOPE treatment of donation after brain death liver grafts may reduce early HCC recurrence after LT. Although only nonsignificant trends were observed in recurrence-free survival and overall survival within the first 2 y posttransplant, these results underscore the potential of HOPE to influence oncological outcomes. Long-term follow-up, prospective randomized controlled trials, and basic research are warranted to further elucidate the role of HOPE and IRI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001883","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T20:00:07Z","timestamp":1765396807000},"page":"e1883","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Propensity Score-matched Real-world Data: HCC Recurrence Rates After DBD Liver Transplantation in Times of Machine Perfusion"],"prefix":"10.1097","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7409-0032","authenticated-orcid":false,"given":"Dominik Thomas","family":"Koch","sequence":"first","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucca","family":"Pollety","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Schirren","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Jacobi","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"B\u00f6rner","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Lange","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, LMU University Hospital, LMU Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ilmer","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich, Germany."},{"name":"Division of General Surgery, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Andrassy","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Renz","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Nie\u00df","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Werner","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Guba","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysios","family":"Koliogiannis","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"R1-20251210","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/lt.20837","article-title":"Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.","volume":"12","author":"Otto","year":"2006","journal-title":"Liver Transpl"},{"key":"R2-20251210","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.suronc.2018.08.007","article-title":"Development of novel biological resection criteria for safe and oncologically satisfying resection of hepatocellular carcinoma.","volume":"27","author":"Schoenberg","year":"2018","journal-title":"Surg Oncol"},{"key":"R3-20251210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-0012.2005.00277.x","article-title":"Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.","volume":"19","author":"Hu","year":"2005","journal-title":"Clin Transplant"},{"key":"R4-20251210","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/SLA.0000000000001866","article-title":"Liver resection and transplantation for patients with hepatocellular carcinoma beyond milan criteria.","volume":"264","author":"Zaydfudim","year":"2016","journal-title":"Ann Surg"},{"key":"R5-20251210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/TP.0b013e3182a89383","article-title":"Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies.","volume":"97","author":"Zheng","year":"2014","journal-title":"Transplantation"},{"key":"R6-20251210","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jhep.2010.07.044","article-title":"Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.","volume":"54","author":"Li","year":"2011","journal-title":"J Hepatol"},{"key":"R7-20251210","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/SLA.0b013e318273bad0","article-title":"Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy?","volume":"256","author":"Adam","year":"2012","journal-title":"Ann Surg"},{"key":"R8-20251210","doi-asserted-by":"crossref","first-page":"13891","DOI":"10.3389\/ti.2025.13891","article-title":"Mono-HOPE versus dual-HOPE in liver transplantation: a propensity score-matched evaluation of early graft outcome.","volume":"38","author":"Koch","year":"2025","journal-title":"Transpl Int"},{"key":"R9-20251210","doi-asserted-by":"crossref","first-page":"9747","DOI":"10.3390\/ijms23179747","article-title":"Mitochondria and cancer recurrence after liver transplantation\u2014what is the benefit of machine perfusion?","volume":"23","author":"Parente","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R10-20251210","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/bjs.9868","article-title":"Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation.","volume":"102","author":"Orci","year":"2015","journal-title":"Br J Surg"},{"key":"R11-20251210","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/SLA.0000000000001473","article-title":"First comparison of hypothermic oxygenated PErfusion versus static cold storage of human donation after cardiac death liver transplants: an international-matched case analysis.","volume":"262","author":"Dutkowski","year":"2015","journal-title":"Ann Surg"},{"key":"R12-20251210","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-6143.2009.02932.x","article-title":"Hypothermic machine preservation in human liver transplantation: the first clinical series.","volume":"10","author":"Guarrera","year":"2010","journal-title":"Am J Transplant"},{"key":"R13-20251210","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.3390\/jcm11247381","article-title":"Hypothermic oxygenated machine perfusion (HOPE) prior to liver transplantation mitigates post-reperfusion syndrome and perioperative electrolyte shifts.","volume":"11","author":"Horn\u00e9","year":"2022","journal-title":"J Clin Med"},{"key":"R14-20251210","doi-asserted-by":"crossref","first-page":"848352","DOI":"10.3389\/fimmu.2022.848352","article-title":"The effect of hypothermic machine perfusion to ameliorate ischemia-reperfusion injury in donor organs.","volume":"13","author":"Knijff","year":"2022","journal-title":"Front Immunol"},{"key":"R15-20251210","first-page":"CD014685","article-title":"Machine perfusion in liver transplantation.","volume":"9","author":"Tingle","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-20251210","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/bjs.10515","article-title":"Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death.","volume":"104","author":"van Rijn","year":"2017","journal-title":"Br J Surg"},{"key":"R17-20251210","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/SLA.0000000000004258","article-title":"Hypothermic oxygenated liver perfusion (HOPE) prevents tumor recurrence in liver transplantation from donation after circulatory death.","volume":"272","author":"Mueller","year":"2020","journal-title":"Ann Surg"},{"key":"R18-20251210","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/aor.14715","article-title":"The role of cold ischemia time and hypothermic perfusion in predicting early hepatocellular carcinoma recurrences after liver transplantation.","volume":"48","author":"Dajti","year":"2024","journal-title":"Artif Organs"},{"key":"R19-20251210","doi-asserted-by":"crossref","first-page":"773535","DOI":"10.3389\/fonc.2021.773535","article-title":"Ischemic-Free liver transplantation reduces the recurrence of hepatocellular carcinoma after liver transplantation.","volume":"11","author":"Tang","year":"2021","journal-title":"Front Oncol"},{"key":"R20-20251210","doi-asserted-by":"crossref","first-page":"101393","DOI":"10.1016\/j.jhepr.2025.101393","article-title":"Ischemia-free liver transplantation improves long-term outcomes in a 5-year follow-up study.","volume":"7","author":"Jia","year":"2025","journal-title":"JHEP Rep"},{"key":"R21-20251210","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/jpm13050703","article-title":"Impact of hypothermic oxygenated machine perfusion on hepatocellular carcinoma recurrence after liver transplantation.","volume":"13","author":"Rigo","year":"2023","journal-title":"J Pers Med"},{"key":"R22-20251210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"R23-20251210","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/SLA.0000000000004280","article-title":"mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumors.","volume":"272","author":"Schnitzbauer","year":"2020","journal-title":"Ann Surg"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T20:00:10Z","timestamp":1765396810000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001883","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]}}}